STAT November 11, 2024
Emraclidine was a centerpiece of the company’s purchase of Cerevel Therapeutics
AbbVie said Monday that its experimental treatment for schizophrenia failed to significantly help patients in two trials, a blow to the company, which got the drug through its recent...